GlassScriptPhysician profile
Sam S Huang
NPI 1841248812
$71,485.55
in general payments reported to CMS, 2019-2025
100 companies · $8,232 in 2025
The $8,232 reported for 2025 was more than what 87% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,181 · 2020: $16K · 2021: $5,222 · 2022: $12K · 2023: $8,880 · 2024: $12K · 2025: $8,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $14K · Education: $223 · Honoraria: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,388.75 |
| Food and Beverage | $14,248.72 |
| Education | $223.32 |
| Honoraria | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $14,300.22 | 2020-2024 | Tecartus, Yescarta |
| Astrazeneca Pharmaceuticals LP | $8,848.72 | 2019-2025 | Imfinzi, Calquence, Lynparza |
| Incyte Corporation | $4,926.79 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Athenex Pharmaceutical Division, LLC | $4,025.00 | 2020 | |
| Janssen Scientific Affairs, LLC | $2,712.78 | 2019 | |
| Celgene Corporation | $2,619.74 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Janssen Biotech, INC. | $2,483.80 | 2019-2025 | Erleada, Darzalex, Tecvayli |
| Beigene USA, INC. | $2,303.07 | 2020-2024 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $2,279.02 | 2019-2025 | Alunbrig, Fruzaqla, Ninlaro |
| Daiichi Sankyo INC. | $2,059.13 | 2019-2025 | Vanflyta, Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $1,599.00 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $1,507.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,401.60 | 2019-2025 | Opdivo, Opdualag |
| Novartis Pharmaceuticals Corporation | $1,328.66 | 2019-2025 | |
| Genzyme Corporation | $1,146.62 | 2019-2025 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $844.62 | 2019-2025 | Bavencio |
| Abbvie INC. | $841.67 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $767.40 | 2019-2023 | Imbruvica |
| Eisai INC. | $764.55 | 2019-2025 | |
| Glaxosmithkline, LLC. | $759.41 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Astellas Pharma US INC | $751.99 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Amgen INC. | $694.50 | 2019-2025 | Vectibix, Nplate, Xgeva |
| Bayer Healthcare Pharmaceuticals INC. | $680.28 | 2019-2025 | |
| Lilly USA, LLC | $641.48 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Exelixis INC. | $626.50 | 2019-2025 | Cabometyx |
| Seagen INC. | $583.05 | 2019-2023 | Tukysa, Padcev, Tivdak |
| Aveo Pharmaceuticals, INC. | $560.58 | 2021-2025 | Fotivda |
| Gilead Sciences, INC. | $554.98 | 2019-2025 | Trodelvy |
| Genentech USA, INC. | $535.87 | 2019-2025 | Polivy, Tecentriq, Lunsumio |
| Puma Biotechnology, INC. | $484.15 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $483.96 | 2019-2025 | Libtayo |
| Array Biopharma INC | $458.51 | 2020-2025 | Braftovi, Mektovi, Tukysa |
| Alexion Pharmaceuticals, INC. | $439.47 | 2021-2025 | Ultomiris |
| Covis Pharma Gmbh | $400.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $381.48 | 2019-2024 | Gilotrif |
| Karyopharm Therapeutics INC. | $377.55 | 2020-2025 | Xpovio |
| Cardinal Health 110 LLC | $375.00 | 2020-2025 | |
| Taiho Oncology, INC. | $265.43 | 2020-2025 | |
| Ipsen Biopharmaceuticals, INC | $227.33 | 2021-2025 | Somatuline Depot, Onivyde |
| Stemline Therapeutics INC. | $219.52 | 2023-2025 | Orserdu, Elzonris |
| Blueprint Medicines Corporation | $204.55 | 2020-2023 | Ayvakit |
| Novocure Gmbh | $200.00 | 2022 | |
| Morphosys, US INC. | $153.99 | 2021-2023 | Monjuvi |
| Sobi, INC | $148.94 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $136.62 | 2019-2025 | |
| Genmab U.S., INC. | $129.06 | 2023-2025 | Epkinly |
| Tesaro, INC. | $127.91 | 2019 | |
| Amag Pharmaceuticals, INC. | $126.76 | 2019-2022 | |
| Ge Healthcare | $126.43 | 2022-2025 | |
| Epizyme, INC. | $122.71 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $118.26 | 2019-2024 | Pyrukynd |
| Pharmaessentia USA Corporation | $112.32 | 2023-2025 | Besremi |
| Coherus Oncology, INC. | $110.50 | 2021-2022 | |
| Clovis Oncology, INC. | $103.41 | 2019-2020 | |
| Comsort, INC | $100.00 | 2019 | |
| Csl Behring | $92.90 | 2019-2024 | Afstyla, Idelvion |
| Verastem, INC. | $92.81 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $92.27 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $91.56 | 2022-2025 | Monoferric |
| Tersera Therapeutics LLC | $90.28 | 2019-2023 | Quzyttir |
| Mylan Institutional INC. | $89.47 | 2019-2021 | |
| Adc Therapeutics America, INC. | $87.29 | 2022-2025 | |
| Becton, Dickinson and Company | $85.07 | 2024 | Venovo |
| Myovant Sciences INC. | $84.11 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $70.89 | 2023-2024 | Orgovyx |
| Foundation Medicine, INC. | $69.18 | 2019-2023 | |
| Cti Biopharma Corp. | $60.69 | 2022-2023 | Vonjo |
| Syndax Pharmaceuticals, INC. | $59.96 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $59.35 | 2019 | |
| Acrotech Biopharma INC. | $53.73 | 2021-2024 | Beleodaq |
| Accord Healthcare, INC. | $53.10 | 2023-2025 | |
| Deciphera Pharmaceuticals INC. | $52.38 | 2023-2024 | Qinlock, Tgct |
| Rigel Pharmaceuticals, INC. | $51.96 | 2020-2025 | Gavreto, Rezlidhia, Tavalisse |
| Dendreon Pharmaceuticals LLC | $50.34 | 2020-2023 | Provenge |
| Dova Pharmaceuticals | $47.00 | 2019-2021 | |
| Immunocore Limited | $46.88 | 2024 | Kimmtrak |
| Beone Medicines USA, INC. | $45.94 | 2025 | Brukinsa, Tevimbra |
| Eusa Pharma (US) LLC | $43.46 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $39.94 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $38.76 | 2023-2025 | Sancuso |
| Servier Pharmaceuticals LLC | $38.72 | 2022-2024 | |
| Iovance Biotherapeutics, INC. | $36.91 | 2025 | Amtagvi |
| Sanofi-Aventis U.S. LLC | $34.10 | 2019-2021 | |
| Mirati Therapeutics, INC. | $33.91 | 2023 | Krazati |
| Helsinn Therapeutics (U.S.), INC. | $32.64 | 2019 | |
| Aurobindo Pharma USA, INC. | $30.97 | 2020 | |
| Legend Biotech USA INC. | $28.39 | 2024 | |
| Alnylam Pharmaceuticals INC. | $28.34 | 2020 | |
| Acceleron Pharma, INC. | $26.15 | 2021 | |
| Myriad Genetic Laboratories, INC. | $25.05 | 2020 | |
| Genentech, INC. | $23.62 | 2023 | Lunsumio, Columvi |
| Immunogen, INC. | $23.39 | 2023 | Elahere |
| Caris Mpi, INC. | $22.92 | 2025 | Mi Cancer Seek |
| Apellis Pharmaceuticals, INC. | $21.61 | 2023 | Empaveli |
| Immunomedics, INC. | $20.99 | 2020 | |
| G1 Therapeutics, INC. | $20.05 | 2023 | Cosela |
| Tg Therapeutics, INC. | $19.46 | 2022 | |
| Geron Corporation | $19.43 | 2025 | Rytelo |
| Novocure INC. | $18.02 | 2020 | |
| Recordati_rare_diseases_inc. | $17.13 | 2023 | Sylvant |
Drugs and devices associated with these payments
Imfinzi $4,590Alunbrig $1,873Tecartus $1,610Erleada $1,467Calquence $952Brukinsa $837Reblozyl $749Vanflyta $728Keytruda $695Enhertu $467Fotivda $459Imbruvica $376Epkinly $368Lynparza $366Ultomiris $356Jakafi $344Monjuvi $315Opdivo $315Cabometyx $300Padcev $293Braftovi $270Mektovi $270Libtayo $258Lenvima $253Xtandi $241Tukysa $236Welireg $205Orserdu $201Ojjaara $197Opdualag $191Inlyta $182Pemazyre $174Darzalex $172Kisqali $171Fruzaqla $169Xpovio $155Lonsurf $155Inqovi $155Elahere $151Tecvayli $149Jaypirca $149Verzenio $147Venclexta $145Gilotrif $145Elrexfio $140Lorbrena $138Rybrevant $138Pomalyst $136Nubeqa $135Fabhalta $131Sarclisa $126Jemperli $124Zejula $123Trodelvy $122Talzenna $114Besremi $112Somatuline Depot $109Onivyde $109Adcetris $107Polivy $106Orgovyx $104Lutathera $103Zynyz $99.18Bosulif $92.22Piqray $91.28Doptelet $91.22Tecentriq $91.09Xofigo $89.68Venovo $85.07Vyloy $84.59Jevtana $78.64Yescarta $76.99Nerlynx $75.32Monoferric $75.32Stivarga $74.17Ziihera $72.22Carvykti $71.59Idelvion $71.27Afstyla $71.27Balversa $66.65Ibrance $64.85Bavencio $64.59Zynlonta $63.25Tivdak $61.63Promacta $57.75Retevmo $57.32Datroway $56.73Lunsumio $56.39Columvi $56.39Mekinist $54.53Ayvakit $54.15Camcevi $53.10Qinlock $52.38Scemblix $52.18Keytruda Qlex $49.38Pyrukynd $49.17Kimmtrak $46.88Akeega $45.17Vitrakvi $44.00Vonjo $43.41
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.